MENU
+Compare
RGC
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$24.60
Change
-$0.65 (-2.57%)
Capitalization
12.16B

RGC Regencell Bioscience Holdings Limited Forecast, Technical & Fundamental Analysis

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people’s immune systems... Show more

RGC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RGC with price predictions
Dec 24, 2025

Momentum Indicator for RGC turns positive, indicating new upward trend

RGC saw its Momentum Indicator move above the 0 level on December 04, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for RGC just turned positive on December 02, 2025. Looking at past instances where RGC's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .

RGC moved above its 50-day moving average on December 04, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RGC crossed bullishly above the 50-day moving average on December 12, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where RGC advanced for three days, in of 138 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 121 cases where RGC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 13 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RGC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RGC broke above its upper Bollinger Band on December 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RGC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RGC's P/B Ratio (2500.000) is very high in comparison to the industry average of (24.311). P/E Ratio (0.000) is within average values for comparable stocks, (74.353). RGC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.954). RGC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.000) is also within normal values, averaging (64.216).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RGC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
RGC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Movies Or Entertainment
Address
29 Leighton Road
Phone
+852 21550823
Employees
12
Web
https://www.regencellbioscience.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PRVS28.200.15
+0.54%
Parnassus Value Select ETF
XLII25.280.07
+0.29%
State Street® IndstrlSelSectSPDR®PrmETF
FDEC51.510.14
+0.28%
FT Vest US Equity Buffer ETF Dec
PICB23.940.02
+0.08%
Invesco International Corporate Bond ETF
STXD37.31N/A
N/A
Strive 1000 Dividend Growth ETF

RGC and Stocks

Correlation & Price change

A.I.dvisor tells us that RGC and QNTM have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGC and QNTM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGC
1D Price
Change %
RGC100%
-2.57%
QNTM - RGC
21%
Poorly correlated
-8.14%
SBFM - RGC
20%
Poorly correlated
N/A
CPHI - RGC
13%
Poorly correlated
-0.76%
ANIP - RGC
11%
Poorly correlated
+1.80%
SUPN - RGC
7%
Poorly correlated
+0.12%
More

Groups containing RGC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGC
1D Price
Change %
RGC100%
-2.57%
Pharmaceuticals: Generic
industry (212 stocks)
11%
Poorly correlated
+0.28%